Crowdonomics
All companies
Ei. Ventures, Inc. logo

Ei. Ventures, Inc.

Operating

Biotech · Kihei, HI

Estimated pre-money ⓘ
$296.4M
As of Mar 2021 · from Reg A Offering (2021) · our estimate: offering price × shares outstanding, not a stated valuation
Total raised
$22,545,139
Crowd $21.6M · Private $923K · 3 rounds since 2020
Latest share price
$0.1647
Reg A+ · Equity · Mar 2021 offering price · in today's shares

Financials

FY2018–FY2021 · from SEC filings · hover any figure for its source
$0
2018
$0
2019
$0
−$667K
2020
$0
−$8.8M
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2018 reviewed*
FY2019 audited
FY2020 audited
FY2021 audited
Income statement
Revenue
$0
$0
$0
$0
Cost of goods sold
$0
$0
$0
$0
Net income
$0
$0
-$666,974
-$8,821,619
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$0
$0
$63,289
$5,642,766
Accounts receivable
$0
$0
$0
$2,904,485
Total assets
$0
$0
$79,289
$10,437,337
Short-term debt
$0
$0
$2,500
$21,173
Long-term debt
$0
$0
$743,763
$4,720,027
Total liabilities
$0
$0
$746,263
$4,741,200
Other
Headcount
—
2
2
2

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$296.4M
est. pre-money
Reg A+ · Equity · Mar 2021

Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Cap table

Share counts as of Mar 18, 2021
ClassOutstandingVotes / shareShare of totalLast price
Common Stock60,000,000—100.0%$0.1647Mar 2021

Principal holders% as the filing states it, Dec 31, 2020

  • Orthogonal Thinker, Inc.100.0%of company

Sold to the crowd

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $922.8KInvestors 120
Reg A+ · Equity · Mar 2021Closedvia DALMORE GROUP LLC
Raised $21.6M / $50MEst. pre-money $296.4M
Reg CF · Debt · Nov 2020Closedvia Fundme.com, Inc.
Raised $40K / $1.1M

Team

6 people
Cecil Robles
Chief Strategy Officer
Cecilio Robles
Chief Strategy Officer
David Nikzad
Director and President
Linda Strause
Director of Clinical Trials
Jason A. Hobson
Director, Treasurer, and Secretary
Jason Hobson
Director

Names and titles as disclosed on SEC Form C, SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 2 of 6 annual reports (FY2020–FY2025)

120 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

  • Form 1-UFeb 23, 20230001104659-23-024573
    EDGAR
  • Form 1-UNov 7, 20220001104659-22-115509
    EDGAR
  • Form 1-SASep 26, 20220001104659-22-102825
    EDGAR
  • Form DSep 8, 20220001945278-22-000003
    EDGAR
  • Form C-ARMay 26, 20220001104659-22-064765
    EDGAR
  • Form 1-KMay 25, 20220001104659-22-064334
    EDGAR
  • Form 1-UMay 23, 20220001104659-22-063527
    EDGAR
  • Form C-ARMar 22, 20220001644600-22-000034
    EDGAR
Source: SEC EDGARCIK 0001823182DEShare price $4.94Last synced Aug 16, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.